
Medpace Holdings (MEDP) Stock Forecast & Price Target
Medpace Holdings (MEDP) Analyst Ratings
Bulls say
Medpace Holdings is poised for growth as it anticipates an increase of 200-300 basis points in passthrough revenues in the second half of the year compared to the already elevated levels in the second quarter. The company is benefiting from strong request-for-proposal (RFP) volume, particularly in the first quarter, which supports a positive outlook for its book-to-bill ratio, with expectations to exceed 1.15x in the third quarter. Collectively, these factors indicate robust operational performance and market demand, reinforcing a favorable financial outlook for Medpace.
Bears say
Medpace Holdings has experienced concerning trends in backlog cancellations, which remained high and were recently noted to be at the upper range of what the company considers normal, indicating potential volatility in future revenue streams. The firm's uncertainty regarding growth in Direct Service revenue further adds to apprehensions, as the company finds it premature to make definitive growth projections while expressing a mild expectation of stability through 2026. Additionally, despite a slight upward adjustment in adjusted EBITDA estimates for 2025 and 2026, the outlook is tempered by the need for continued investment in hiring and a forecasted decrease in passthrough revenues, raising questions about long-term profitability and financial sustainability.
This aggregate rating is based on analysts' research of Medpace Holdings and is not a guaranteed prediction by Public.com or investment advice.
Medpace Holdings (MEDP) Analyst Forecast & Price Prediction
Start investing in Medpace Holdings (MEDP)
Order type
Buy in
Order amount
Est. shares
0 shares